| Tretinoin | Approved Investigational Nutraceutical | MYLIP | 29116 |
upregulated | Tretinoin results in increased expression of MYLIP mRNA | 6p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MYLK | 4638 |
downregulated | Tretinoin results in decreased expression of MYLK mRNA | 3q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MYO10 | 4651 |
downregulated | Tretinoin results in decreased expression of MYO10 mRNA | 5p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MYO15A | 51168 |
downregulated | Tretinoin results in decreased expression of MYO15A mRNA | 17p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MYO5B | 4645 |
downregulated | Tretinoin results in decreased expression of MYO5B mRNA | 18q | |
| Tretinoin | Approved Investigational Nutraceutical | MYO5B | 4645 |
upregulated | Tretinoin results in increased expression of MYO5B mRNA | 18q | |
| Tretinoin | Approved Investigational Nutraceutical | MYO5C | 55930 |
downregulated | Tretinoin results in decreased expression of MYO5C mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MYO6 | 4646 |
upregulated | Tretinoin results in increased expression of MYO6 mRNA | 6q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MYO9A | 4649 |
upregulated | Tretinoin results in increased expression of MYO9A mRNA | 15q23 | |
| Tretinoin | Approved Investigational Nutraceutical | MYOF | 26509 |
upregulated | Tretinoin results in increased expression of MYOF mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | MYOZ2 | 51778 |
upregulated | Tretinoin results in increased expression of MYOZ2 mRNA | 4q26 | |
| Tretinoin | Approved Investigational Nutraceutical | N4BP2L1 | 90634 |
downregulated | Tretinoin results in decreased expression of N4BP2L1 mRNA | 13q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | N4BP2L2 | 10443 |
downregulated | Tretinoin results in decreased expression of N4BP2L2 mRNA | 13q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NAE1 | 8883 |
downregulated | Tretinoin results in decreased expression of NAE1 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NAGLU | 4669 |
upregulated | Tretinoin results in increased expression of NAGLU mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NAMPT | 10135 |
upregulated | Tretinoin results in increased expression of NAMPT mRNA | 7q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NANOG | 79923 |
downregulated | Tretinoin results in decreased expression of NANOG mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | NANOS1 | 340719 |
downregulated | Tretinoin results in decreased expression of NANOS1 mRNA | 10q26.11 | |
| Tretinoin | Approved Investigational Nutraceutical | NANOS1 | 340719 |
upregulated | Tretinoin results in increased expression of NANOS1 mRNA | 10q26.11 | |
| Tretinoin | Approved Investigational Nutraceutical | NANOS3 | 342977 |
downregulated | Tretinoin results in decreased expression of NANOS3 mRNA | 19p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | NANS | 54187 |
downregulated | Tretinoin results in decreased expression of NANS mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NAP1L1 | 4673 |
downregulated | Tretinoin results in decreased expression of NAP1L1 mRNA | 12q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NAP1L2 | 4674 |
downregulated | Tretinoin results in decreased expression of NAP1L2 mRNA | Xq13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NAP1L5 | 266812 |
upregulated | Tretinoin results in increased expression of NAP1L5 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NASP | 4678 |
downregulated | Tretinoin results in decreased expression of NASP mRNA | 1p34.1 | |